EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuroinflammation is linked to dementia risk in Parkinson’s disease

Antonina Kouli, Lennart R B Spindler, Tim D Fryer, Young T Hong, Maura Malpetti iD, Franklin I Aigbirhio, Simon R White, Marta Camacho iD, John T O'Brien iD, Caroline H Williams-Gray iD

Brain · 01.03.2024 · 147 (3) · 923-935

DOI: 10.1093/brain/awad322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 27.09.2023. Verfasst von Antonina Kouli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0PY, UK. Hauptthemen laut MEDLINE: Parkinson Disease, Dementia. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Evelyn Trust, UKRI Research Innovation Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of dementia is a devastating aspect of Parkinson’s disease (PD), affecting nearly half of patients within 10 years post-diagnosis. For effective therapies to prevent and slow progression to PD dementia (PDD), the key mechanisms that determine why some people with PD develop early dementia, while others remain cognitively unaffected, need to be understood. Neuroinflammation and tau protein accumulation have been demonstrated in post-mortem PD brains, and in many other neurodegenerative disorders leading to dementia. However, whether these processes mediate dementia risk early on in the PD disease course is not established. To this end, we used PET neuroimaging with 11C-PK11195 to index neuroinflammation and 18F-AV-1451 for misfolded tau in early PD patients, stratified according to dementia risk in our ‘Neuroinflammation and Tau Accumulation in Parkinson’s Disease Dementia’ (NET-PDD) study. The NET-PDD study longitudinally assesses newly-diagnosed PD patients in two subgroups at low and high dementia risk (stratified based on pentagon copying, semantic fluency, MAPT genotype), with comparison to age- and sex-matched controls. Non-displaceable binding potential (BPND) in 43 brain regions (Hammers’ parcellation) was compared between groups (pairwise t-tests), and associations between BPND of the tracers tested (linear-mixed-effect models). We hypothesized that people with higher dementia risk have greater inflammation and/or tau accumulation in advance of significant cognitive decline. We found significantly elevated neuroinflammation (11C-PK11195 BPND) in multiple subcortical and restricted cortical regions in the high dementia risk group compared with controls, while in the low-risk group this was limited to two cortical areas. The high dementia risk group also showed significantly greater neuroinflammation than the low-risk group concentrated on subcortical and basal ganglia regions. Neuroinflammation in most of these regions was associated with worse cognitive performance (Addenbrooke’s Cognitive Examination-III score). Overall neuroinflammation burden also correlated with serum levels of pro-inflammatory cytokines. In contrast, increases in 18F-AV-1451 (tau) BPND in PD versus controls were restricted to subcortical regions where off-target binding is typically seen, with no relationship to cognition found. Whole-brain 18F-AV-1451 burden correlated with serum phosphorylated tau181 levels. Although there was minimal regional tau accumulation in PD, regional neuroinflammation and tau burden correlated in PD participants, with the strongest association in the high dementia risk group, suggesting possible co-localization of these pathologies. In conclusion, our findings suggest that significant regional neuroinflammation in early PD might underpin higher risk for PDD development, indicating neuroinflammation as a putative early modifiable aetiopathological disease factor to prevent or slow dementia development using immunomodulatory strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDementiaHumansNeuroinflammatory DiseasesBasal GangliaInflammationDisease Progression

Stichwörter der Autor:innen

PET imagingParkinson’s diseasedementiainflammationtau

Autor:innen und Institutionen

  • Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0PY, UK.
  • Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, CB2 0QQ, UK.
  • Medical Research Council Biostatistics Unit, Cambridge Institute of Public Health, Cambridge, CB2 0SL, UK.
  • Department of Psychiatry, University of Cambridge, Cambridge, CB2 0SZ, UK.

ORCID-Profile: Maura Malpetti, Marta Camacho, John T O'Brien, Caroline H Williams-Gray

Förderung

  • Medical Research Council
  • Evelyn Trust
  • UKRI Research Innovation Fellowship
  • Race Against Dementia & Alzheimer’s Research UK
  • UKRI Medical Research Council
  • Cambridge Centre for Parkinson-Plus
  • NIHR Cambridge Biomedical Research Centre
  • Department of Health and Social Care

Zitieren

APA

Kouli, A., Spindler, L. R. B., Fryer, T. D., Hong, Y. T., Malpetti, M., Aigbirhio, F. I., White, S. R., Camacho, M., O'Brien, J. T., & Williams-Gray, C. H. (2024). Neuroinflammation is linked to dementia risk in Parkinson’s disease. Brain, 147(3), 923-935. https://doi.org/10.1093/brain/awad322

Vancouver

Kouli A, Spindler LRB, Fryer TD, Hong YT, Malpetti M, Aigbirhio FI, et al. Neuroinflammation is linked to dementia risk in Parkinson’s disease. Brain. 2024;147(3):923-935. doi:10.1093/brain/awad322

BibTeX
@article{Kouli2024,
  author = {Kouli, Antonina and Spindler, Lennart R B and Fryer, Tim D and Hong, Young T and Malpetti, Maura and Aigbirhio, Franklin I and White, Simon R and Camacho, Marta and O'Brien, John T and Williams-Gray, Caroline H},
  title = {Neuroinflammation is linked to dementia risk in Parkinson’s disease},
  journal = {Brain},
  year = {2024},
  volume = {147},
  number = {3},
  pages = {923--935},
  doi = {10.1093/brain/awad322}
}
Kostenlos starten →